General Atlantic exits Jubilant Life Sciences

The private equity (PE) firm has reportedly sold its stake in the lifesciences major for Rs 145 crore, as per reports


In 2005, The Private Equity (PE) major General Atlantic had invested around Rs 240 crore in Jubilant

General Atlantic has sold its six percent stake in Jubilant Life Sciences for about Rs 145 crore via open market transactions over the past month, according to reports.

Reportedly, on May 5, General Atlantic sold its 5.49 percent stake at Rs 150 per share aggregating to around Rs 131 crore. Earlier, on April 7, General Atlantic had offloaded another 0.5 percent stake for nearly Rs 14 crore at approximately Rs 173 per share.

The Private Equity (PE) major,  General Atlantic had invested around Rs 240 crore in Jubilant Life Sciences to fund the pharma company's growth and acquisition plans in 2005.



Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email